OpenURL Connection Search

Select item for more details and to access through your institution.

Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00970-z
By:
- Pennings, Elise R. A.;
- Durmaz, Müjde;
- Visser, Otto;
- Posthuma, Eduardus F. M.;
- Issa, Djamila E.;
- Chamuleau, Martine E. D.;
- Lugtenburg, Pieternella J.;
- Kersten, Marie José;
- Dinmohamed, Avinash G.
Publication type:
Article
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Published in:
Cancers, 2023, v. 15, n. 22, p. 5443, doi. 10.3390/cancers15225443
By:
- de Boer, Janneke W.;
- Keijzer, Kylie;
- Pennings, Elise R. A.;
- van Doesum, Jaap A.;
- Spanjaart, Anne M.;
- Jak, Margot;
- Mutsaers, Pim G. N. J.;
- van Dorp, Suzanne;
- Vermaat, Joost S. P.;
- van der Poel, Marjolein W. M.;
- van Dijk, Lisanne V.;
- Kersten, Marie José;
- Niezink, Anne G. H.;
- van Meerten, Tom
Publication type:
Article
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Published in:
Cancers, 2023, v. 15, n. 17, p. 4334, doi. 10.3390/cancers15174334
By:
- Spanjaart, Anne M.;
- Pennings, Elise R. A.;
- Mutsaers, Pim G. N. J.;
- van Dorp, Suzanne;
- Jak, Margot;
- van Doesum, Jaap A.;
- de Boer, Janneke W.;
- Niezink, Anne G. H.;
- Kos, Milan;
- Vermaat, Joost S. P.;
- Sijs-Szabo, Aniko;
- van der Poel, Marjolein W. M.;
- Nijhof, Inger S.;
- Kuipers, Maria T.;
- Chamuleau, Martine E. D.;
- Lugtenburg, Pieternella J.;
- Doorduijn, Jeanette K.;
- Serroukh, Yasmina I. M.;
- Minnema, Monique C.;
- van Meerten, Tom
Publication type:
Article

Found: 3

Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.

Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.

The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.